UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 3, 2004 ________________ PEDIATRIX MEDICAL GROUP, INC. ____________________________________________________ (Exact name of registrant as specified in its charter) FLORIDA 0-26762 65-0271219 _______ _______ __________ (State or other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification No.) 1301 Concord Terrace Sunrise, Florida 33323-2825 __________________________________________________________ (Address of principal executive offices, including zip code) Registrant's telephone number, including area code: (954) 384-0175 ______________ (Former Name or Former Address, if Changed Since Last Report) Item 12. Information Furnished Under Item 12 (Results of Operations and Financial Condition) On February 3, 2004, Pediatrix Medical Group, Inc. issued a press release announcing its results of operations for the three months and 12 months ended December 31, 2003 and expanding previously-issued 2004 earnings guidance to include a breakdown of earnings per share by quarter, as well as estimated cash flow from operations for 2004. The press release is attached as an exhibit hereto and is incorporated herein by reference. (c). Exhibits 99.1 Press Release of Pediatrix Medical Group, Inc., dated February 3, 2004. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PEDIATRIX MEDICAL GROUP, INC. Date: February 3, 2003 By: /s/ Karl B. Wagner ______________________________ Karl B. Wagner Chief Financial Officer EXHIBIT INDEX _____________ EXHIBIT NO. DESCRIPTION ___________ ___________ 99.1 Press Release dated February 3, 2004.